Us Bancorp \De\ Seres Therapeutics, Inc. Transaction History

Us Bancorp \De\

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$4.95 - $6.09 $866 - $1,065	175 New	175 $0
Q2 2022 Aug 01, 2022	SELL	$2.7 - $7.62 $672 - $1,897	-249 Closed	0 $0
Q1 2022 May 11, 2022	SELL	$6.3 - $8.84 $144 - $203	-23 Reduced 8.46%	249 $2,000
Q4 2021 Feb 11, 2022	BUY	$6.02 - $11.43 $138 - $262	23 Added 9.24%	272 $2,000
Q3 2021 Nov 10, 2021	BUY	$5.46 - $22.6 $1,190 - $4,926	218 Added 703.23%	249 $2,000

Q2 2021 Aug 05, 2021	BUY	$18.46 - $24.36 $572 - $755	31 New	31 $1,000
Q2 2018 Aug 08, 2018	SELL	$6.91 - $9.55 $760 - $1,050	-110 Closed	0 $0
Q3 2017 Nov 13, 2017	BUY	$12.81 - $16.85 $1,409 - $1,853	110	110 $2,000

100

62.7M

36.9K

476K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $89.3M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Us Bancorp \De\, based on Form 13F filings with the SEC.

Stay updated on Us Bancorp \De\ with notifications on news.